<DOC>
	<DOCNO>NCT01303224</DOCNO>
	<brief_summary>Irritable Bowel Syndrome diarrhoea ( IBS-D ) functional gastrointestinal disorder characterise chronic recurrent abdominal pain discomfort diarrhoea . This trial aim evaluation efficacy safety neurokinin type 2 receptor antagonist Ibodutant improve IBS-D symptom .</brief_summary>
	<brief_title>Ibodutant Relief Irritable Bowel Syndrome With Diarrhoea ( IBS-D )</brief_title>
	<detailed_description>The study evaluate efficacy safety three dos ibodutant , give daily 8 week versus placebo IBS-D patient . Efficacy evaluate term overall symptom relief abdominal pain/discomfort relief 8 week treatment . The clinical phase study comprise 2-week run-in period ( treatment-free ) , 8-week double-blind treatment period 2-week treatment withdrawal period , result 10-week overall duration study patient . Patients report IBS-related symptom daily electronic diary ( web-and telephone base ) period study .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>At start runin period : Male female patient age 18 70 year clinical diagnosis IBSD accord Rome III criterion : Recurrent abdominal pain/discomfort least 3 day per month last 3 month associate least 2 follow characteristic : 1. improvement defecation ; 2. onset associate change frequency stool ; 3. onset associate change form ( appearance ) stool . Symptomonset least 6 month prior diagnosis . Loose/watery stool least 25 % time last 3 month AND hard/lumpy stool le 25 % time last 3 month . More 3 bowel movement per day least 25 % time last 3 month . For patient old 50 year OR patient positive family history colorectal cancer : Normal result colonoscopy flexible sigmoidoscopy . Mentally competent , able give write informed consent . For woman childbearing potential : Use highly effective contraceptive method throughout entire study period 30 day posttreatment . Normal physical examination without clinically relevant abnormality . At randomisation : Confirmation IBSD severity term bowel movement frequency abdominal pain intensity along 2week runin period . Exclusion criterion : Organic abnormalities gastrointestinal tract , include history colonic major abdominal surgery . History gluten enteropathy . Lactose intolerance assess response diet . History positive test ova parasite , occult blood stool . Previous diagnosis diabetes mellitus ( either type 1 2 ) . Unstable medical condition . Major psychiatric , neurological , cardiovascular disorder , uncontrolled metabolic disease . Relevant change dietary habit , lifestyle , exercise regimen previous 2 month . Use concurrent medication drug know interfere gastrointestinal motility sensitivity . Pregnancy breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Irritable Bowel Syndrome</keyword>
	<keyword>Colon , irritable</keyword>
	<keyword>Bowel disease</keyword>
</DOC>